Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN · Real-Time Price · USD
2.820
-0.020 (-0.70%)
At close: Feb 27, 2026, 4:00 PM EST
2.870
+0.050 (1.77%)
After-hours: Feb 27, 2026, 7:34 PM EST
Lantern Pharma Market Cap
Lantern Pharma has a market cap or net worth of $31.54 million as of February 27, 2026. Its market cap has decreased by -39.20% in one year.
Market Cap
31.54M
Enterprise Value
19.27M
1-Year Change
-39.20%
Ranking
Category
Stock Price
$2.82
Market Cap Chart
Since June 11, 2020, Lantern Pharma's market cap has increased from $30.33M to $31.54M, an increase of 3.99%. That is a compound annual growth rate of 0.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 31.54M | -6.93% |
| Dec 31, 2025 | 33.89M | -1.50% |
| Dec 31, 2024 | 34.40M | -26.05% |
| Dec 29, 2023 | 46.52M | -29.06% |
| Dec 30, 2022 | 65.58M | -26.55% |
| Dec 31, 2021 | 89.28M | -25.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Outlook Therapeutics | 34.95M |
| CEL-SCI | 34.48M |
| INmune Bio | 34.29M |
| RenovoRx | 32.36M |
| ABVC BioPharma | 32.35M |
| Tempest Therapeutics | 30.74M |
| NeuroSense Therapeutics | 30.35M |
| AN2 Therapeutics | 30.14M |